All News

Daniel Shoskes, MD, presents the take home messages on transplantation/vascular surgery from the AUA annual meeting in San Diego.

Mantu Gupta, MD, presents the take home messages on stone disease/endourology from the AUA annual meeting in San Diego.

Hunter Wessells, MD, presents the take home messages on trauma/reconstruction/diversion from the AUA annual meeting in San Diego.

Harcharan Singh Gill, MD, presents the take home messages on penile, testis, and urethral cancer from the AUA annual meeting in San Diego.

Robert C. Dean, MD, presents the take home messages on sexual function/dysfunction from the AUA annual meeting in San Diego.

Priya Padmanabhan, MD, MPH, presents the take home messages on female urology/incontinence/urodynamics from the AUA annual meeting in San Diego.

James Brown, MD, presents the take home messages on minimally invasive surgery from the AUA annual meeting in San Diego.

Danil V. Makarov, MD, MHS, presents the take home messages on outcomes analysis.

A study of more than 1,800 men ages 52 to 62 years suggests that African-Americans diagnosed with very low-risk prostate cancers are much more likely than Caucasian men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.

The use of advanced treatments-namely, intensity-modulated radiation therapy and robotic prostatectomy-in patients with low-risk prostate cancer has increased significantly, despite little evidence of benefit, according to a recently published study from the University of Michigan Comprehensive Cancer Center, Ann Arbor.

Andrew Wagner, MD, presents the take home messages on kidney cancer from the AUA annual meeting in San Diego.

Newly elected AUA President Pramod C. Sogani, MD, discusses the AUA's new regional courses on advanced prostate cancer treatment and its expanded course offerings in urologic ultrasound, among other topics.

A new prognostic test for prostate cancer outperformed existing risk assessment tools for predicting metastatic disease in patients following radical prostatectomy, researchers reported.

Caldera Medical has announced FDA clearance and the launch of Vertessa Lite, which Caldera calls a supple, lightweight, yet strong polypropylene mesh for use in abdominal sacrocolpopexy procedures for vaginal vault prolapse.

Aaron Spitz, MD, presents the take home messages on infertility/andrology from the AUA annual meeting in San Diego.

Hari K. Koul, MSc, PhD, presents the take home messages on basic science research at the AUA annual meeting in San Diego.

Jeannette M. Potts, MD, presents the take home messages on infection and inflammation at the AUA annual meeting in San Diego.

Jay D. Raman, MD, presents the take home messages on prostate cancer from the AUA annual meeting in San Diego.

Physicians and their advocates scored important victories in Connecticut, Florida, and Georgia in working to defeat attempts to undermine past medical liability reform successes and achieving new ones.

Estrogen supplements may help menopausal women ward off recurrent urinary tract infections, researchers recently reported.

Observation appears to be safe and more cost effective than immediate treatment for many men with low-risk, localized prostate cancer, according to a recent study from Dana-Farber Cancer Institute and Massachusetts General Hospital, Boston.

The need to equalize or narrow Medicare payment differences between ambulatory services provided in hospital outpatient departments (OPDs) and physicians’ offices is urgent, according to the Medicare Payment Advisory Commission (MedPAC).

Early exposure to bisphenol A (BPA) leads to an increased cancer risk in an animal model of human prostate cancer, according to new research findings from the University of Illinois at Chicago.

The amount of money that has been spent by payers and vendors with deep lobbying pockets has made the delay of ICD-10 implementation highly unlikely. As such, we are recommending that every practice assume that Oct. 1, 2014 is the implementation date.

“Our group all felt that we were caught off guard," said one urologist about the AUA's new prostate cancer screening guideline.

A relatively new imaging system demonstrates a higher capacity for mapping recurrent prostate cancer than integrated positron emission tomography and computed tomography, researchers recently reported at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver, British Columbia.

The use of computed tomography scans of the head, abdomen/pelvis, chest, or spine in children younger than 14 years of age more than doubled from 1996 to 2005, according to a study of seven U.S. health care systems.

Men with prostate cancer may significantly improve their survival chances with a simple change in their diet, according to a recent study.